Will biotech see an uptick in M&A?
The biopharma M&A market has slowed since 2019. But is a buyer’s market emerging?
Archives for July 19, 2022
Samsung Biologics buys land for Second Bio Campus
CDMO Samsung Biologics has signed a land purchase agreement with the Incheon Free Economic Zone (IFEZ) to create its second Bio Campus.
Continued smallpox vaccine orders provide ‘robust’ base for Bavarian Nordic into 2023
Bavarian Nordic continues to sign contracts for its smallpox vaccine in response to the monkeypox outbreak, with the company again raising its financial guidance for 2022 and noting orders now stretch into 2023.
SK bioscience to manufacture Novavax’s Omicron COVID-19 vaccine
SK bioscience has extended its partnership with Novavax to include the manufacture and supply of Novavax’s Omicron COVID-19 vaccine candidate, which could become available later this year.